Brooks, Houghton Serves as M&A Adviser to Generex Biotechnology Corporation on Final Tranche Acquisition

Healthcare / Pharmaceuticals / MedTech / Lifescience
Deal description: 

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the second and final tranche acquisition of remaining operating assets from Veneto Holdings, L.L.C. ("Veneto") and certain of its affiliated entities (collectively, the "Veneto Group").

In 2018, Brooks Houghton, member of Globalscope, the international M&A network, provided advisory services to Generex Biotechnology Corporation based in United States in an M&A transaction with Veneto Holdings, LLC, based in United States. Please contact Brooks Houghton for more details.

« Back to transactions